For the Inventor, By the Inventor

Enter assignee name

Tarrytown, NY, United States of America

Regeneron Pharmaceuticals, Inc.

USPTO Granted Patents = 1,482

% Expired Patents = 4.9

CIPO Patents = 54

EPO Patents = 481

Trademarks = 60

Forward Citations = 12,627

Loading Chart...

Loading Chart...

941 inventors (with patents filed for the assignee):

Andrew J Murphy (344 out of 368 patents)

George D Yancopoulos (194 out of 204 patents)

Lynn Macdonald (183 out of 192 patents)

4. Sean Stevens (158 out of 166 patents)

5. Cagan Gurer (101 out of 104 patents)

6. Nicholas J Papadopoulos (90 out of 93 patents)

7. David M Valenzuela (88 out of 92 patents)

8. Gang Chen (77 out of 78 patents)

9. Gavin Thurston (75 out of 79 patents)

10. James P Fandl (67 out of 68 patents)

11. Samuel H Davis (67 out of 72 patents)

12. Joel H Martin (59 out of 61 patents)

13. William C Olson (58 out of 88 patents)

14. Shunhai Wang (56 out of 62 patents)

15. Eric L Smith (56 out of 88 patents)

Core Competencies:

Antibodies

Drug Delivery

T Cell Engineering

Bioconjugates

Cancer Therapies

Mass Spectrometry

Gene Editing

Protein Formulations

Chimeric Antigen Receptors

Biopharmaceuticals

Immunotherapy

Chromatography

1,482 patents: Sort by Forward Citations

1. 12760347 - CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN (2026-10-13),

2. 12760122 - MICE THAT MAKE VL BINDING PROTEINS (2026-10-13),

3. 12760112 - Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A (2026-10-13),

4. 12754181 - Extraction methods for evaluating suitability of a biochemical filter (2026-10-06),

5. 12753205 - PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS (2026-10-06),

6. 12747300 - Methods and Antibody Compositions for Tumor Treatment (2026-09-29),

7. 12747287 - Methods of identifying and evaluating cat allergy gene signatures in a subject by determining a stratified score based on gene expression (2026-09-29),

8. 12746301 - Methods and systems for sterilization (2026-09-29),

9. 12745761 - NON-HUMAN ANIMALS HAVING HUMANIZED FC-GAMMA RECEPTORS (2026-09-29),

10. 12742195 - Genotyping by sequencing (2026-09-22),

11. 12741098 - Devices and methods for precision dose delivery (2026-09-22),

12. 12736541 - Target-based method for high-throughput and subclass specific IgG glycan profiling in human plasma (2026-09-15),

13. 12735752 - Methods of identifying subjects having an increased risk of developing a coronavirus infection and treatment thereof (2026-09-15),

14. 12735496 - METHODS OF TREATING AN INTERLEUKIN-2 RECEPTOR GAMMA-MEDIATED DISEASE OR CONDITION BY ADMINISTERING AN IL2 RECEPTOR GAMMA ANTIBODY (2026-09-15),

15. 12735469 - MAGE-A4 T CELL RECEPTORS AND METHODS OF USE THEREOF (2026-09-15),

Company Overview

Regeneron Pharmaceuticals, Inc. is a leading biopharmaceutical company based in Tarrytown, New York, specializing in the development of innovative therapies for serious medical conditions. The company focuses on advanced technologies such as antibodies, T cell engineering, and gene editing to create effective cancer therapies and bioconjugates. With a commitment to scientific excellence, Regeneron employs cutting-edge methods like mass spectrometry and protein formulations to enhance drug delivery and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

1,482 Patents

#3 in Tarrytown, NY

#21 in New York

#334 in US

#665 in the World

Tarrytown, NY, United States of America

Regeneron Pharmaceuticals, Inc.

Forward Citations = 12,627

941 inventors:

Andrew J Murphy (344 out of 368 patents)

George D Yancopoulos (194 out of 204 patents)

Lynn Macdonald (183 out of 192 patents)

4. Sean Stevens (158 out of 166 patents)

5. Cagan Gurer (101 out of 104 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Regeneron Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/regeneron-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…